Genetic testing study for sarcoma patients and relatives
Part of Cancer clinical trials.
This study looks at how people think about and respond to genetic testing for a specific genetic change found in sarcoma (a type of cancer). It aims to understand beliefs and attitudes toward this testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or a close relative must have been diagnosed with a type of sarcoma called LMS (leiomyosarcoma)
- A specific genetic change (called a germline PV) linked to sarcoma was found in research testing but you haven't had it confirmed yet
- You are 18 years or older
- You can speak and read English
- You are mentally able to make decisions for yourself
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at lab markers (biomarkers) in tumor samples from people with leiomyosarcoma that has spread or can’t be fully removed. It also enrolls people who are receiving certain first-line chemotherapy, and your results may help guide future treatment decisions.
This study tests the genes of your cancer to learn more about advanced breast, lung, melanoma, or sarcoma tumors. It may help doctors find better ways to treat these cancers in the future.
This study tests a new way to offer genetic testing to young adults (ages 18-39) who have or had cancer. The goal is to make it easier for you to learn if you have inherited gene changes that could affect your cancer and your family's health.
This study tests different ways to help family members of people with inherited cancer syndromes get genetic testing. It aims to improve cancer prevention and early detection.
This study looks at how parents and children communicate after learning about an inherited (genetic) cancer risk. It may help researchers find better ways to support families in these conversations.
This study looks at cancer-related inherited gene changes using blood samples. It may help patients and doctors understand cancer risk and guide treatment planning, especially across different ethnic communities.
Hear when a new Leiomyosarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.